Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +33.64%
#3 Cysic Cysic +25.00%
#4 Nockchain Nockchain +18.92%
#5 Velvet Velvet +18.00%
#6 Perle Perle +14.46%
#7 FOLKS FOLKS +13.61%
#8 Nillion Nillion +12.50%
#9 Versatize Coin Versatize Coin +12.49%
#10 Starpower Starpower +10.78%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
Adiuvo Investments S.A. Adiuvo Investments S.A.

Adiuvo Investments S.A.

ADV
Rank in Stocks #37492
Adiuvo Investments S.A. operates as a venture capital firm, deploying capital... Adiuvo Investments S.A. operates as a venture capital firm, deploying capital across the entire spectrum of business development, from initial incubation and seed funding to supporting early-stage, startup, and growth-phase companies. Its primary investment focus lies in the medical devices, digital health, and nutraceuticals sectors, specifically targeting opportunities within Poland. The firm typically commits up to €3 million (approximately $3.35 million) per venture, with an intended holding period of three to five years. All investments are made directly from Adiuvo's own balance sheet. Established in 2013, the company maintains its headquarters in Warsaw, Poland.
Share Price
$0.12668455
Last synced: 2026-08-14
Market Cap
$1.67M
Change (1 day)
-4.26%
Change (1 year)
-43.21%
Country
PL
Trade Adiuvo Investments S.A. (ADV)

Category

Healthcare
P/E ratio for Adiuvo Investments S.A. (ADV)
P/E ratio as of 2026 TTM: 0
According to Adiuvo Investments S.A. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Adiuvo Investments S.A. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 35.77 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 34.86 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 20.90 -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 52.64 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.